AG尊龙凯时

      Reliable Quality

      Affordable Innovation

      Name Indication Clinical Trial Phase Study Title
      HLX01
      DLBCL
      Phase III

      Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

      HLX01
      RA
      Phase I/II

      A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

      HLX01
      RA
      Phase III

      A Phase III Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis